reports
Independent Research
- Independent Research
Full Report Available at Radiopharm Theranostics Limited (ASX:RAD) is a newly listed company on the ASX with the Company commencing trading on 25 November 2021. The Company is focused on developing nuclear medicines to treat cancer with a diversified portfolio of radiopharmaceutical diagnostic and therapeutic (theranostic) candidates.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.